Tejnaksh Healthcare 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Ashish Rawandale-Patil

최고 경영자

₹600.0k

총 보상

CEO 급여 비율	100.0%
CEO 임기	9.7yrs
CEO 소유권	38.3%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	9.8yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Ashish Rawandale-Patil 의 보수는 Tejnaksh Healthcare 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	₹22m
Jun 30 2024	n/a	n/a	₹22m
Mar 31 2024	₹600k	₹600k	₹18m
Dec 31 2023	n/a	n/a	₹13m
Sep 30 2023	n/a	n/a	₹10m
Jun 30 2023	n/a	n/a	₹13m
Mar 31 2023	₹500k	₹500k	₹17m
Dec 31 2022	n/a	n/a	₹22m
Sep 30 2022	n/a	n/a	₹26m
Jun 30 2022	n/a	n/a	₹25m
Mar 31 2022	₹300k	₹300k	₹27m
Dec 31 2021	n/a	n/a	₹30m
Sep 30 2021	n/a	n/a	₹29m
Jun 30 2021	n/a	n/a	₹27m
Mar 31 2021	₹700k	₹700k	₹21m
Dec 31 2020	n/a	n/a	₹12m
Sep 30 2020	n/a	n/a	₹12m
Jun 30 2020	n/a	n/a	₹14m
Mar 31 2020	₹2m	₹2m	₹21m
Dec 31 2019	n/a	n/a	₹34m
Sep 30 2019	n/a	n/a	₹34m
Jun 30 2019	n/a	n/a	₹32m
Mar 31 2019	₹1m	₹1m	₹30m
Dec 31 2018	n/a	n/a	₹25m
Sep 30 2018	n/a	n/a	₹26m
Jun 30 2018	n/a	n/a	₹27m
Mar 31 2018	₹878k	₹878k	₹29m

보상 대 시장: Ashish 의 총 보상 ($USD 7.11K ) Indian 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 42.63K ).

보상과 수익: Ashish 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Ashish Rawandale-Patil (53 yo)

9.7yrs

테뉴어

₹600,000

보상

Dr. Ashish Vishwas Rawandale-Patil has been Managing Director of Tejnaksh Healthcare Limited since March 19, 2015 and serves as its Chairman. Dr. Rawandale-Patil has been Director at Tejnaksh Healthcare Li...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Ashish Rawandale-Patil	Chairman & MD	16.8yrs	₹600.00k	38.3% ₹ 182.1m
Preeti Rawandale	Non Executive Non Independent Director	16.8yrs	₹600.00k	35.53% ₹ 168.9m
Kiran Pawar	Non-Executive Independent Director	9.8yrs	데이터 없음	데이터 없음
Vikramsingh Satish Patil	Non-Executive Independent Director	9.8yrs	데이터 없음	데이터 없음
Sanjay Khatal	Non-Executive Non Independent Director	4.3yrs	데이터 없음	데이터 없음
Suhas Thorat	Additional Non-Executive Independent Director	3.3yrs	데이터 없음	데이터 없음

9.8yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 이사회: 539428 의 이사회는 경험(평균 재직 기간 9.8 년)으로 간주됩니다.

Tejnaksh Healthcare 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 28, 2024

Insufficient new directors

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 21, 2023

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 28, 2022

Recent updates

Second quarter 2025 earnings released: EPS: ₹0.31 (vs ₹0.28 in 2Q 2024)

Tejnaksh Healthcare Limited to Report Q2, 2025 Results on Nov 14, 2024

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 28, 2024

Insufficient new directors

First quarter 2025 earnings released: EPS: ₹0.29 (vs ₹0.08 in 1Q 2024)

Tejnaksh Healthcare Limited to Report Q1, 2025 Results on Aug 14, 2024

Investor sentiment improves as stock rises 19%

Full year 2024 earnings released: EPS: ₹0.87 (vs ₹0.83 in FY 2023)

Investor sentiment improves as stock rises 16%

Tejnaksh Healthcare Limited to Report Q4, 2024 Results on May 28, 2024

Third quarter 2024 earnings released: EPS: ₹0.27 (vs ₹0.15 in 3Q 2023)

Tejnaksh Healthcare Limited to Report Q3, 2024 Results on Feb 12, 2024

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: ₹0.28 (vs ₹0.41 in 2Q 2023)

Tejnaksh Healthcare Limited to Report Q2, 2024 Results on Nov 11, 2023

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 21, 2023

First quarter 2024 earnings released

Tejnaksh Healthcare Limited to Report Q1, 2024 Results on Aug 12, 2023

Investor sentiment improves as stock rises 111%

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: ₹1.66 (vs ₹2.68 in FY 2022)

Investor sentiment deteriorates as stock falls 15%

Investor sentiment deteriorates as stock falls 16%

Investor sentiment deteriorates as stock falls 15%

Third quarter 2023 earnings released: EPS: ₹0.31 (vs ₹0.67 in 3Q 2022)

Tejnaksh Healthcare Limited to Report Q3, 2023 Results on Feb 11, 2023

Tejnaksh Healthcare Limited Launches Product Catheter Caresimulator

Tejnaksh Healthcare Limited Launches New Product Andro-Sim

Second quarter 2023 earnings released: EPS: ₹0.82 (vs ₹0.73 in 2Q 2022)

Tejnaksh Healthcare Limited Innovates PCNL Simulator and changed the practice of PCNL training

Tejnaksh Healthcare Limited, Annual General Meeting, Sep 28, 2022

First quarter 2023 earnings released: EPS: ₹0.55 (vs ₹0.75 in 1Q 2022)

Investor sentiment improved over the past week

Tejnaksh Healthcare Limited to Report Q4, 2022 Results on May 17, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS ₹0.73 (vs ₹0.57 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS ₹0.75

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹2.02 (vs ₹2.06 in FY 2020)

Investor sentiment improved over the past week

Non-Executive Independent Director Pratap Patil has left the company

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹0.60 (vs ₹0.58 in 3Q 2020)

New 90-day high: ₹61.05

Tejnaksh Healthcare Limited to Report Q3, 2021 Results on Feb 13, 2021

Investor sentiment improved over the past week

New 90-day high: ₹54.40

Investor sentiment improved over the past week

Market bids up stock over the past week

New 90-day high: ₹42.30

Tejnaksh Healthcare Limited to Report Q2, 2021 Results on Nov 13, 2020

Tejnaksh Healthcare Limited to Report Q1, 2021 Results on Sep 15, 2020

Tejnaksh Healthcare Limited Provides Financial Guidance for the Financial Year 2020-21

New 90-day low - ₹38.00

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령